US Patent Issued to Dompe' Farmaceutici on July 15 for "IL-17A binding peptides and medical uses thereof" (Italian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,950, issued on July 15, was assigned to Dompe' Farmaceutici S.P.A. (Milan).

"IL-17A binding peptides and medical uses thereof" was invented by Marcello Allegretti (L'Aquila, Italy), Andrea Aramini (L'Aquila, Italy), Andrea Beccari (L'Aquila, Italy), Marica Gemei (Naples, Italy) and Flavio Mantelli (L'Aquila, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to IL-17A binding peptides, inhibitors of the interaction of IL-17A with the receptor IL-17RA, and to bioconjugates, dimers, pharmaceutical compositions and medical use thereof."

The patent was filed on Dec. 17, 2021, under Application No. 17/555,154.

*For further infor...